Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis
Abstract Background Nasopharyngeal carcinoma (NPC) is one of the most common head and neck cancers worldwide. The majority of the new cases were from Asia and are the leading cause of cancer in China. The main treatment is surgery and radiotherapy with chemotherapy for advanced cases. With the advan...
Saved in:
Main Authors: | Htet Htet, Jwala Rebacca James Anaghan, Heethal Jaiprakash, Ismail Abdul Sattar Burud, Thiruselvi Subramaniam, Igor Iezhitsa, Renu Agarwal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13528-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reproduction outcomes and prognostic significance of pregnancy after nasopharyngeal carcinoma treatment
by: Meijuan Luo, et al.
Published: (2025-12-01) -
The prognostic value of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer
by: Mustafa Kandaz, et al.
Published: (2025-01-01) -
EMC2 suppresses ferroptosis via regulating TFRC in nasopharyngeal carcinoma
by: Xianghui Chen, et al.
Published: (2025-02-01) -
Dosimetry of automatic non-coplanar volumetric-modulated arc therapy for nasopharyngeal carcinoma
by: Kaiqiang Chen, et al.
Published: (2025-02-01) -
Longitudinal functional outcomes and late effects of radiation following treatment of nasopharyngeal carcinoma: secondary analysis of a prospective cohort study
by: Gia Gill, et al.
Published: (2022-11-01)